突破性治疗药*CDE

**Breakthrough Therapy Drugs** The China Food and Drug Administration (CFDA) has established a **Breakthrough Therapy Designation** to expedite the development and review of drugs that are intended to treat serious or life-threatening conditions. This designation is intended to provide patients with earlier access to potentially life-saving treatments.